Grifols PE Ratio 2012-2019 | GRFS

Current and historical p/e ratio for Grifols (GRFS) from 2012 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Grifols PE ratio as of May 17, 2019 is 15.96.
Grifols PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-05-17 18.35 24.47
2019-03-31 20.11 $0.75 26.81
2018-06-30 21.25 $0.98 21.69
2017-06-30 20.46 $0.90 22.73
2017-03-31 18.13 $0.91 19.93
2016-12-31 15.44 $0.90 17.15
2016-09-30 15.14 $0.67 22.60
2016-06-30 15.81 $0.67 23.59
2016-03-31 14.53 $0.65 22.53
2015-12-31 15.22 $0.66 23.05
2015-09-30 14.11 $0.88 16.13
2015-06-30 14.38 $0.87 16.62
2015-03-31 15.06 $0.85 17.72
2014-12-31 15.60 $0.88 17.73
2014-09-30 15.98 $0.81 19.73
2014-06-30 20.04 $0.76 26.55
2014-03-31 18.67 $0.74 25.40
2013-12-31 16.32 $0.67 24.37
2013-09-30 13.69 $0.62 22.07
2013-06-30 12.87 $0.57 22.42
2013-03-31 12.98 $0.52 25.06
2012-12-31 11.60 $0.47 24.62
2012-09-30 9.73 $0.39 25.22
2012-06-30 8.18 $0.32 25.27
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.617B $5.299B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.809B 31.18
Takeda Pharmaceutical (TAK) Japan $27.294B 10.10
Ionis Pharmaceuticals (IONS) United States $9.458B 20.67
Sage Therapeutics (SAGE) United States $8.591B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.885B 10.80
Neurocrine Biosciences (NBIX) United States $7.214B 0.00
Catalent (CTLT) United States $6.611B 26.53
Nektar Therapeutics (NKTR) United States $5.581B 9.10
Tilray (TLRY) Canada $4.419B 0.00
United Therapeutics (UTHR) United States $3.971B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.964B 12.76
FibroGen (FGEN) United States $3.082B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.560B 9.22
PTC Therapeutics (PTCT) United States $2.275B 0.00
Portola Pharmaceuticals (PTLA) United States $2.013B 0.00
Xencor (XNCR) United States $1.931B 52.72
Arrowhead Pharmaceuticals (ARWR) United States $1.845B 278.00
Pacira Pharmaceuticals (PCRX) United States $1.806B 87.46
Aerie Pharmaceuticals (AERI) United States $1.794B 0.00
Tricida (TCDA) United States $1.772B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.771B 24.20
USANA Health Sciences (USNA) United States $1.763B 15.32
Ironwood Pharmaceuticals (IRWD) United States $1.741B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.590B 0.00
Zogenix (ZGNX) United States $1.587B 0.00
Endo (ENDP) Ireland $1.475B 2.37
Heron Therapeutics (HRTX) United States $1.430B 0.00
Esperion Therapeutics (ESPR) United States $1.392B 0.00
Corcept Therapeutics (CORT) United States $1.247B 17.80
Theravance Biopharma (TBPH) Cayman Islands $1.158B 0.00
TURNING PT THER (TPTX) United States $1.016B 0.00
Radius Health (RDUS) United States $0.971B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.924B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.809B 0.00
TherapeuticsMD (TXMD) United States $0.803B 0.00
ArQule (ARQL) United States $0.741B 0.00
ChemoCentryx (CCXI) United States $0.722B 0.00
Aptorum Group (APM) China $0.716B 0.00
Akebia Therapeutics (AKBA) United States $0.648B 0.00
ORGANOGENESIS (ORGO) United States $0.636B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.632B 0.00
CannTrust Holdings (CTST) Canada $0.632B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.604B 0.00
Odonate Therapeutics (ODT) United States $0.597B 0.00
Dermira (DERM) United States $0.564B 0.00
GlycoMimetics (GLYC) United States $0.535B 0.00
Translate Bio (TBIO) United States $0.510B 0.00
Flexion Therapeutics (FLXN) United States $0.476B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.468B 23.65
Corbus Pharmaceuticals Holdings (CRBP) United States $0.456B 0.00
Siga Technologies (SIGA) United States $0.452B 1.06
Collegium Pharmaceutical (COLL) United States $0.418B 0.00
Mast Therapeutics (SVRA) United States $0.411B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.390B 0.00
OptiNose (OPTN) United States $0.378B 0.00
Forty Seven (FTSV) United States $0.378B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 0.00
TCR2 Therapeutics (TCRR) United States $0.337B 0.00
Xeris Pharmaceuticals (XERS) United States $0.334B 0.00
ImmunoGen (IMGN) United States $0.307B 0.00
Dova Pharmaceuticals (DOVA) United States $0.304B 0.00
CASI Pharmaceuticals (CASI) United States $0.302B 0.00
Karyopharm Therapeutics (KPTI) United States $0.282B 0.00
Harpoon Therapeutics (HARP) United States $0.279B 0.00
Molecular Templates (MTEM) United States $0.275B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.261B 0.00
Concert Pharmaceuticals (CNCE) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.239B 0.00
MEI Pharma (MEIP) United States $0.237B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.237B 0.00
Lannett Co Inc (LCI) United States $0.236B 2.29
Aclaris Therapeutics (ACRS) United States $0.233B 0.00
Minerva Neurosciences (NERV) United States $0.231B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.229B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.226B 0.00
Calithera Biosciences (CALA) United States $0.221B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.221B 0.00
Rafael Holdings (RFL) United States $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
Aldeyra Therapeutics (ALDX) United States $0.201B 0.00
Recro Pharma (REPH) United States $0.199B 0.00
Opexa Therapeutics (ACER) United States $0.193B 0.00
IMV INC (IMV) Canada $0.191B 0.00
Majesco Entertainment (PTE) United States $0.189B 0.00
Ardelyx (ARDX) United States $0.187B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 59.06
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.169B 0.00
Redhill Biopharma (RDHL) Israel $0.168B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.166B 0.00
Jounce Therapeutics (JNCE) United States $0.161B 0.00
Tyme Technologies (TYME) United States $0.152B 0.00
Ocular Therapeutix (OCUL) United States $0.148B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.148B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.145B 0.00
Neon Therapeutics (NTGN) United States $0.144B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.135B 0.00
Aquestive Therapeutics (AQST) United States $0.126B 0.00
Bio Blast Pharma (ENLV) Israel $0.124B 0.00
DURECT (DRRX) United States $0.121B 0.00
MediWound (MDWD) Israel $0.121B 0.00
AgeX Therapeutics (AGE) United States $0.116B 0.00
Nivalis Therapeutics (ALPN) United States $0.111B 0.00
ProNAi Therapeutics (SRRA) Canada $0.109B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.101B 72.22
Cardiome Pharma (CORV) Canada $0.100B 0.00
Iterum Therapeutics (ITRM) Ireland $0.099B 0.00
Champions Oncology (CSBR) United States $0.099B 0.00
China SXT Pharmaceuticals (SXTC) China $0.099B 0.00
Natural Alternatives (NAII) United States $0.097B 9.67
Zafgen (ZFGN) United States $0.093B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.090B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.087B 0.00
Otonomy (OTIC) United States $0.086B 0.00
Neos Therapeutics (NEOS) United States $0.085B 0.00
Infinity Pharmaceuticals (INFI) United States $0.084B 0.00
Adherex Technologies (FENC) United States $0.081B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.078B 0.00
SCYNEXIS (SCYX) United States $0.077B 0.00
Capnia (SLNO) United States $0.062B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.056B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.051B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.049B 0.00
AIT Therapeutics (AITB) Israel $0.047B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
India Globalization Capital (IGC) United States $0.047B 0.00
CTI BioPharma (CTIC) United States $0.046B 0.00
Lipocine (LPCN) United States $0.046B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Bio-Path Holdings (BPTH) United States $0.044B 0.00
Novan (NOVN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
BioLineRx (BLRX) Israel $0.041B 0.00
ContraFect (CFRX) United States $0.039B 0.00
KemPharm (KMPH) United States $0.038B 0.00
Melinta Therapeutics (MLNT) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
IsoRay (ISR) United States $0.030B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
HANCOCK JAFFE (HJLI) United States $0.027B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Regulus Therapeutics (RGLS) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.022B 2.93
PharmAthene (ALT) United States $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Shineco (TYHT) China $0.019B 3.11
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Trillium Therapeutics (TRIL) Canada $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.97
VAXART, INC (VXRT) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.007B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.007B 0.00
Can-Fite Biopharma (CANF) Israel $0.007B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00